---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-039470"
form_type: "8-K/A"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2026-02-05T23:59:59+00:00"
generated_at: "2026-05-16T04:19:17.352493+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro files financials for acquired IRRAS; IRRAS cash from ops -$11.4M in 2024

## Summary
- IRRAS 2024 operating cash outflow $11.4M; accumulated deficit $105.3M.
- Gross accounts receivable $1.67M with $22.5K credit loss allowance.
- Convertible notes of $6.33M at 5% interest; fair value adjustment recorded $219.6K expense.

## SEC filing metadata
- accession: 0001193125-26-039470
- form_type: 8-K/A
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2026-02-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000119312526039470/0001193125-26-039470-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000119312526039470/clpt-20251120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-039470
- JSON: https://secwatch.observer/filing/0001193125-26-039470.json
- Plain text: https://secwatch.observer/filing/0001193125-26-039470.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.